Patient Derived Xenograft (PDX) Model Market, By Tumor Type (Prostate Cancer, Pancreatic Cancer, Lung Cancer and Breast Cancer), By Model (Mice and Rats), By End User (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes and CROs & CDMOs), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Patient Derived Xenograft (PDX) Model Market size was valued at USD 290.6 Million in 2022, expanding at a CAGR of 13.2% from 2023 to 2030.
The Patient-Derived Xenografts (PDX) model is a valuable tool in cancer research wherein tumor tissue or cells from a patient are implanted into immunocompromised or humanized mice through xenotransplantation. This procedure allows for the sustained cultivation of cancer post-removal from the patient, facilitating the observation of tumor progression in a laboratory setting and its response to various therapeutic interventions. PDX models enable a personalized approach to oncology by evaluating a patient\'s specific tumor against a range of medications. Additionally, cohorts of PDX models can be employed to assess the efficacy of drugs against diverse cancer types.
Market Dynamics of the Patient-Derived Xenograft (PDX) Model:
The burgeoning global prevalence of cancer serves as a significant driver for market expansion. As evidenced by data from the National Cancer Institutes, the United States alone is expected to host 18.1 million cancer survivors by January 2022, constituting approximately 5.4% of the total population. Among these survivors, 623,405 individuals grapple with metastatic breast, prostate, lung, colorectal, bladder, or melanoma cancers, with a projected increase to 693,452 by 2025.
Furthermore, data from Cancer Research UK highlights the anticipated rise in global cancer cases, with an estimated 28 million new cases annually by 2040 if current incidence rates, population growth, and aging trends persist. This represents a substantial 54.9% increase from 2020, with a more pronounced rise projected for males at 60.6% and slightly lower for females at 48.8%. These compelling statistics underpin the substantial market growth anticipated during the forecast period.
Patient Derived Xenograft (PDX) Model Market- Key Insights
- According to our research analyst\'s assessment, the global Patient-Derived Xenograft (PDX) Model market is poised to experience a robust annual growth rate, estimated at approximately 13.2% throughout the forecast duration spanning from 2023 to 2030.
- The Patient-Derived Xenograft (PDX) Model sector is anticipated to exhibit substantial growth, primarily attributed to the escalating incidence of cancer.
- In terms of tumor classification, the breast cancer segment is foreseen as the dominant force within the market throughout the forecast period.
- When considering geographical distribution, it is expected that North America will maintain its prominence in the market throughout the forecast period.
Patient Derived Xenograft (PDX) Model Market- Segmentation Analysis:
The Global Patient-Derived Xenograft (PDX) Model Market exhibits segmentation based on tumor type, model type, end-user, and geographical region.
In terms of tumor classification, the global Patient-Derived Xenograft (PDX) Model market encompasses categories such as prostate cancer, pancreatic cancer, lung cancer, breast cancer, and other malignancies. Notably, the breast cancer segment is poised to exert significant dominance throughout the forecast period.
Despite notable advancements in the detection and treatment of breast cancer, it continues to stand as the foremost cause of mortality among women worldwide. The complexity of breast cancer tumors, characterized by substantial heterogeneity within populations, poses formidable challenges for their eradication using current therapeutic agents. Traditional cancer models, including in vitro and in vivo cell lines, struggle to accurately predict treatment efficacy due to this inter-tumor heterogeneity. Consequently, the development of PDX models has emerged as a crucial advancement, offering a more faithful representation of the intricate variability inherent in human malignancies\' origins. These PDX models hold the potential to enhance the effectiveness of breast cancer treatment modalities, thus driving growth within this segment over the forecast period.
Patient Derived Xenograft (PDX) Model Market- Competitive Landscape:
Prominent companies in the market include WuXi AppTec, XenTech, Crown Bioscience, Altogen Labs, Envigo, Charles River Laboratories, Oncodesign, Hera Biolabs, The Jackson Laboratory, and Abnova Corp.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET KEY PLAYERS
- WuXi AppTec
- XenTech
- Crown Bioscience
- Altogen Labs
- Envigo
- Charles River Laboratories
- Oncodesign
- Hera Biolabs
- The Jackson Laboratory
- Abnova Corp.
GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY TUMOR TYPE
- Prostate Cancer
- Pancreatic Cancer
- Lung Cancer
- Breast Cancer
- Others
GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY MODEL
- Mice
- Rats
GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY END USER
- Pharmaceutical And Biopharmaceutical Companies
- Academic & Research Institutes
- CROs & CDMOs
GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Patient Derived Xenograft (PDX) Model Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Patient Derived Xenograft (PDX) Model Market Snippet by Tumor Type
2.1.2. Patient Derived Xenograft (PDX) Model Market Snippet by Model
2.1.3. Patient Derived Xenograft (PDX) Model Market Snippet by End User
2.1.4. Patient Derived Xenograft (PDX) Model Market Snippet by Country
2.1.5. Patient Derived Xenograft (PDX) Model Market Snippet by Region
2.2. Competitive Insights
3. Patient Derived Xenograft (PDX) Model Key Market Trends
3.1. Patient Derived Xenograft (PDX) Model Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Patient Derived Xenograft (PDX) Model Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Patient Derived Xenograft (PDX) Model Market Opportunities
3.4. Patient Derived Xenograft (PDX) Model Market Future Trends
4. Patient Derived Xenograft (PDX) Model Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Patient Derived Xenograft (PDX) Model Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Patient Derived Xenograft (PDX) Model Market Landscape
6.1. Patient Derived Xenograft (PDX) Model Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Patient Derived Xenograft (PDX) Model Market – By Tumor Type
7.1. Overview
7.1.1. Segment Share Analysis, By Tumor Type, 2022 & 2030 (%)
7.1.2. Prostate Cancer
7.1.3. Pancreatic Cancer
7.1.4. Lung Cancer
7.1.5. Breast Cancer
7.1.6. Others
8. Patient Derived Xenograft (PDX) Model Market – By Model
8.1. Overview
8.1.1. Segment Share Analysis, By Model, 2022 & 2030 (%)
8.1.2. Mice
8.1.3. Rats
9. Patient Derived Xenograft (PDX) Model Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
9.1.2. Pharmaceutical And Biopharmaceutical Companies
9.1.3. Academic & Research Institutes
9.1.4. CROs & CDMOs
10. Patient Derived Xenograft (PDX) Model Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Patient Derived Xenograft (PDX) Model Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. WuXi AppTec
11.2.2. XenTech
11.2.3. Crown Bioscience
11.2.4. Altogen Labs
11.2.5. Envigo
11.2.6. Charles River Laboratories
11.2.7. Oncodesign
11.2.8. Hera Biolabs
11.2.9. The Jackson Laboratory
11.2.10. Abnova Corp.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
